Jane Elizabeth Minturn, M.D., Ph.D.
Clinical Professor of Pediatrics (Oncology)
Assistant Physician in Oncology, Division of Oncology, The Children's Hospital of Philadelphia
Full Member-Pediatric Oncology Research Program, Abramson Cancer Center of the University of Pennsylvania
Cancer Center Liaison, Global Patient Services, Children's Hospital of Philadelphia
Director of Clinical Operations, Neuro-Oncology Section, Children’s Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Oncology, HUB 3590
3500 Civic Center Boulevard
Philadelphia, PA 19104
Division of Oncology, HUB 3590
3500 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-426-5026
Fax: 215-590-3296
Fax: 215-590-3296
Publications
Education:
B.S. (Psychobiology)
University of Southern California, 1986.
M.Phil. (Philosophy)
Yale University, 1993.
M.D. (Medicine)
Yale University School of Medicine, 1996.
Ph.D. (Neurobiology)
Yale University, 1996.
Permanent linkB.S. (Psychobiology)
University of Southern California, 1986.
M.Phil. (Philosophy)
Yale University, 1993.
M.D. (Medicine)
Yale University School of Medicine, 1996.
Ph.D. (Neurobiology)
Yale University, 1996.
Description of Research Expertise
Early phase clinical trial development in pediatric central nervous system tumors.Understanding neuro-cognitive late effects in children treated for brain tumors in infancy
Understanding caregiver challenges of young adult survivors of childhood brain tumors
Description of Clinical Expertise
Developmental Therapeutics in Pediatric Brain Tumors.Late Effects in Survivors of Pediatric Brain Tumors
Description of Other Expertise
Division of Oncology Clinical Liaison, Department of Global Patient Services Program, The Children's Hospital of PhiladelphiaSelected Publications
Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco J, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ: Feasibility and safety of high-dose proton re-irradiation in recurrent pediatric central nervous system tumors: a single-institution retrospective study. Pediatric Blood Cancer 4: e70371, May 2026.Barakat LP, Hammer SN, Knafl GJ, Stevens E, Hobbie WL, Minturn JE, Knafl KA, Deatrick JA: Acceptability and feasibility of a problem-solving intervention for maternal caregivers of young adult survivors of childhood brain tumors. Psychooncology 35(2): e70288, Feb 2026.
Wong D, Lin F, Kline C, Wu J, Schubert J, Chen J, Golenberg N, Naveh N, Patel M, Xu F, Cao K, fu W, Denenberg E, Fanning EZ, Gallo D, Zelley K, Belasco J, Desai K, Foster JB, Kotch C, Minturn J, Shah A, Lang SS, Madsen PJ, Hill-Kayser CE, LaRiviere M, Li Y, Wertheim G, Luo M, Surrey LF, Zhong Y, Viaene AN, Brodeur GM, MacFarland SP, Santi M, Resnick A, Storm PB, Fisher MJ, Cole KA, Li MM. : Integrated molecular and clinical analysis of over 500 pediatric central nervous system tumors. Neuro-Oncology Pediatrics "Accepted for publication" 2026.
Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol, A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S: Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNO005. Clin Cancer Res 31(16): 3463, Aug 2025.
Hammer SN, Deatrick JA, Knafl KA, Knafl GJ, Hobbie WL, Stevens E, Minturn JE, Barakat LP: Evaluating a Self- and Family Management Framework for Young Adult Survivors of Childhood Brain Tumors. J Fam Nurs 31(2): 140, May 2025.
Hocking MC, Schultz RT, Fantozzi P, Herrington JD, Yerys BE, Minuturn JE: White matter connectivity and social functioning in survivors of pediatric brain tumor. J Neurooncol 169(2), Sep 2024.
Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller S: Everolimus for Children with Recurrent or Progressive Low-Grade Glioma: Results from the Phase II PNOC001 Trial. J Clin Oncol Feb 2024.
Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R, Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E, Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S, Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE, Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E, Morgenstern DA. : Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency. Clin Cancer Res 29(23): 4770, December 2023.
Kotch C, Elgarten C, Wilhelm D, Schmus, McWhorter J, Li Y, Minturn JE: The impact of proactive gastrostomy tube placement on treatment-related outcomes in young children with high-grade central nervous system tumors. J Pediatr Hematol Oncol 45(6): 333, August 2023.
Gubbiotti MA, Madsen P, Abdullaev Z, Aldape K, Shekdar K, Yang A, Minturn JE, Santi M, Viaene AN: ZFTA-fused supratentorial ependymoma with novel fusion partner, DUX4. J Neuropathol Exp Neurol 82(7): 668, June 2023.